Robot Aims to Improve Minimally Invasive Ear Surgery

A new robotic system, measuring just 1.9 millimeters at its tightest bend, can navigate the ear canal and perform precise procedures deep inside the cochlea. Developed by a team from the Harbin Institute of Technology and Shanghai Ninth People’s Hospital, this device aims to make inner ear diagnosis and treatment more accessible and less invasive. The research, published in *Nature Communications* [DOI: 10.1038/s41467-026-72398-5](https://doi.org/10.1038/s41467-026-72398-5), demonstrates a working prototype tested on cadavers and live animals.

The Anatomical Challenge of Inner Ear Access

Treating or diagnosing diseases of the inner ear, such as sensorineural hearing loss or certain forms of tinnitus, presents a significant physical problem. The cochlea is a tiny, snail-shaped organ buried deep within the temporal bone, accessible only through a long, narrow, and curved pathway—the ear canal and middle ear. Performing a procedure like injecting a drug directly into the cochlear fluid or taking a micro-sample for analysis requires extreme precision and miniaturization. Traditional approaches often involve more invasive surgery.

As lead authors Haiming Li, Peiyuan Gao, and Haoyue Tan explain, existing devices struggle with a core trade-off: they can be small, or they can be dexterous and “smart,” but not all three at once. Their team’s goal was to create a single device that could travel the natural transcanal route, see where it is going, perform a precise task, and sense what it is touching, all without causing trauma.

A Robot That Bends Like a Snake and Feels With Light

The core of the new system is a dual-segment continuum robot. Unlike a rigid surgical tool, it is composed of flexible, saddle-shaped joints that form a smooth, “transition-free” backbone. It is moved by pulling on tiny, antagonistic cables, similar to how tendons control a finger. This design allows it to bend into very tight spaces, achieving a minimum bending radius of 1.9 mm. Critically, the two segments can be controlled independently, allowing the robot to form programmable C- or S-shaped curves to wind its way through anatomical structures.

The robot is multifunctional. A central channel houses a microscopic needle that acts as the end-effector, capable of delivering drugs or collecting fluid samples with an accuracy of under 20 micrometers. An endoscopic camera provides vision. The most notable feature for safety is its sense of touch. The researchers mounted Fiber Bragg Grating (FBG) sensors on the needle itself. These sensors use light to measure minuscule axial forces—essentially, how hard the needle is pushing against tissue. This real-time feedback allows a surgeon to “feel” the interaction and avoid applying damaging force to the delicate structures of the inner ear.

This integration of vision, precise motion, and haptic feedback addresses what the paper calls the “tool-tissue interaction” problem, a major hurdle in delicate microsurgery. Understanding these physical interactions is as important as visualizing the anatomy, a principle also explored in research on facial nerve outcomes in skull base surgery.

Validation in Cadavers and Animal Models

The research team did not stop at bench-top testing. They validated the robotic system in realistic biological environments. Using human cadaveric temporal bones, they demonstrated that the robot could successfully navigate the transcanal pathway and reach the cochlea. This step confirmed the anatomical feasibility of the approach.

They then progressed to in vivo testing in animals. Here, they performed a model procedure: injecting a tracer dye into the cochlea’s scala tympani, one of its fluid-filled chambers. The successful, atraumatic completion of this task in a living model is a strong indicator that the system could be adapted for human procedures. It moves the concept from engineering possibility to medical practicality.

Implications for Hearing Health and Precision Medicine

The practical implications of this technology are broad. It enables “intracochlear theranostics”—combining therapy and diagnostics in a single, minimally invasive procedure. For patients, this could one day mean a clinic visit where a doctor uses this system to sample inner ear fluid to precisely diagnose the cause of sudden hearing loss or tinnitus, then immediately deliver a targeted drug to the exact site of pathology.

This level of precision is a central goal of modern medicine. For complex auditory conditions, accurate diagnosis is the first challenge. While tools like machine learning are helping to classify hearing disorders from clinical data, this robotic system works on the physical level of the diseased organ itself. It could provide the biological samples needed to understand the molecular basis of conditions we currently manage symptomatically.

Furthermore, the transcanal approach is inherently less invasive than traditional surgery. It could reduce patient risk, improve recovery times, and potentially be performed in settings with less specialized surgical infrastructure. The authors suggest this could help “extend precision medicine to underserved areas.”

While not a direct treatment for auditory processing conditions like hyperacusis or misophonia, which involve central brain pathways, this technology targets peripheral ear diseases that often contribute to or coexist with these conditions. By enabling direct intervention in the cochlea, it opens a new front in the effort to preserve and restore hearing function, a foundation for overall auditory health. The journey from animal studies to human clinical use will require further testing, but this work provides a compelling vision of a more accessible and precise future for inner ear medicine.